rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1988-2-18
|
pubmed:abstractText |
In a human case of plasmacytoma we studied plasma and tumor concentrations of melphalan given intravenously. Intratumoral concentration of melphalan was similar to plasma concentration 60 min after the end of infusion.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0344-5704
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
342-3
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:3690809-Aged,
pubmed-meshheading:3690809-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:3690809-Humans,
pubmed-meshheading:3690809-Injections, Intravenous,
pubmed-meshheading:3690809-Male,
pubmed-meshheading:3690809-Melphalan,
pubmed-meshheading:3690809-Oropharyngeal Neoplasms,
pubmed-meshheading:3690809-Pharyngeal Neoplasms,
pubmed-meshheading:3690809-Plasmacytoma,
pubmed-meshheading:3690809-Prednisolone
|
pubmed:year |
1987
|
pubmed:articleTitle |
Intratumoral measurement and plasma pharmacokinetics of intravenously administered melphalan. Report of a patient with plasmacytoma.
|
pubmed:affiliation |
Department of General Oncology, Danderyd's Hospital, Sweden.
|
pubmed:publicationType |
Journal Article,
Case Reports
|